COLLABORATIVE DRUG DISCOVERY FOR ALZHEIMER'S DISEASE
We specialise in drug discovery for Alzheimer's disease. Our established humanised models and high throughput living system screens are a unique and ideal front end for Alzheimer's drug discovery. We can test many thousands of compounds for collaborators and accelerate entry into human trials. To register interest in collaborative work, email email@example.com.
NEURODEGENERATIVE AND CNS DISEASE SERVICES
Brainwave-Discovery also maintains its established service business, providing custom humanised model and assay development services for any CNS disease, and drug testing services in our human neurodegenerative disease models for Alzheimer's, Parkinson's and Huntington's disease. Our living system assays based on world class research at the University of Edinburgh effectively accelerate the drug discovery process.
If you are interested in discussing a collaboration, please contact us. You might be: a company with many chemicals but no current focus in Alzheimer's - work with us to increase the value of your assets; a company specializing in pathway chemical sets - let us see if there are compounds with surprising and valuable effects in your possession; a company interested in Alzheimer's that is open to a new way to start drug discovery. Brainwave Discovery works with several partners in the pharmaceutical industry and plays an active role in a variety of research consortia. If you would like to discuss a potential partnership with us then please contact us.